- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05701111
Building Resilience at Schools: Emotional and Biological Assessment and Treatment of Traumatic Stress
In the last four years alone, residents of Puerto Rico have experienced a slew of natural disasters including Hurricane Maria in 2017, earthquakes in 2019 and 2020, the continued COVID-19 pandemic from 2020-2022, and most recently Hurricane Fiona. This series of distressing events can lead to an increased need for mental health resources and trauma treatment. Furthermore, the unique single-district structure of the Puerto Rican education system allows for the efficient dissemination of potential interventions and treatment to all students.
The purpose of this study is to examine two treatment conditions for educators and school-aged children in Puerto Rico experiencing burnout, fatigue, and high stress: delivery of a mindfulness-based educator curriculum and, for children who report Post Traumatic Stress Disorder (PTSD) symptomatology, delivery of the mindfulness curriculum with the additional intervention of Cue-Centered Therapy (CCT). The study has two aims: 1) To assess the efficacy of the mindfulness curriculum and of CCT in a population of students, counselors, and teachers, characterized by high stress over the last few years of natural disasters and pandemic challenges and 2) To identify genetic contributions to resilience by analyzing gene expression in students before and after the intervention.
The overarching goals of the investigators' research collaboration are to improve educators' psychological well-being and children's socioemotional development when faced with high stress and adversity and to improve mental health clinicians' competence and confidence in treating children exposed to trauma by training them in CCT. The investigators' research will identify critical biopsychosocial components responsible for the cognitive, behavioral, and emotional improvement and effective implementation strategies in a large but geographically dispersed school district. The knowledge base that will result from this study will inform the implementation of trauma-informed care in school settings and with populations experiencing stress and adversity, and contribute to the investigators' understanding of the underlying biology of these interventions to provide a rationale for further development and dissemination.
Study Overview
Status
Conditions
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Lab Adminstrator
- Phone Number: (650) 721-3582
- Email: elsrp_contact@stanford.edu
Study Locations
-
-
-
San Juan, Puerto Rico, 00926
- Suspended
- Centros Sor Isolina Ferre
-
San Juan, Puerto Rico
- Recruiting
- Department of Education Puerto Rico
-
Contact:
- Lab Administrator
- Phone Number: 650-497-8774
- Email: resilienciapr@stanford.edu
-
-
-
-
California
-
Palo Alto, California, United States, 94305
- Not yet recruiting
- Stanford University
-
Contact:
- Lab Administrator
- Phone Number: 650-721-3582
- Email: elsrp_contact@stanford.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Teachers and students at a participating school site, Adults and students/caregivers willing to participate in the study
For Cue Centered Therapy:
- Youth aged 11-17 with exposure to at least one Diagnostic Statistical Manual (DSM) 5-defined traumatic event and meeting threshold criteria for posttraumatic symptoms per the University of California Los Angeles (UCLA) PTSD scale.
- Willingness to participate in therapy
- Caregiver willing to participate in therapy
- Perpetrator of the traumatic event is not living in the home with the child
Exclusion Criteria:
1. For the general study and for Cue Centered Therapy:
- Students doing current trauma-focused interventions with a mental health professional
- Low cognitive functioning (IQ less than 70)
- Substance dependence as defined by DSM criteria
- Autism/Schizophrenia
- Clinically significant medical illness
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Sequential Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Mindfulness Curriculum
Participants will undergo a mindfulness curriculum in the classroom for 6-8 weeks and complete surveys before the start and after completion.
|
The Start with the Heart curriculum includes psychoeducation, lessons, and activities, on mindfulness, neurobiology, meditation, positive thinking, movement, and nutrition to promote well-being.
The curriculum will be taught in the classroom to students for 15-20 min per day for 6-8 weeks.
|
|
Experimental: Teachers
Participants will be trained in the mindfulness curriculum and implement it in the classroom for 6-8 weeks.
They will complete surveys before training and after implementation.
|
Pure Edge Inc will train teachers to deliver the Start with the Heart curriculum.
The training emphasizes the neuroscience of stress and educator self-care.
The teachers will implement the training in their respective classrooms for 6-8 weeks.
|
|
Experimental: Counselors
Participants will be trained in Cue-Centered Therapy and implement the treatment with student clients for 15-18 weeks.
They will complete surveys before training and after 3 months after the start of implementation.
|
The Early Life Stress and Resilience Program team members will train school counselors on Cue-Centered Therapy through self-paced online modules, virtual and in-person live training, and office hours as needed.
Counselors will implement the intervention with eligible students for 15-18 weeks.
|
|
Experimental: CCT
Participants that report PTSD symptomatology during the mindfulness curriculum surveys will be eligible to participate in Cue-Centered Therapy treatment for 15-18 weeks.
They will complete surveys before and after treatment.
|
Students who report a threshold of PTSD symptoms will be offered participation in Cue-Centered Therapy with their school counselors.
They will have one-on-one therapy that targets trauma experiences through cognitive behavioral tools, narrative therapy, exposure therapy, psychoeducation, and more.
Their caregivers will be involved as needed.
They will enroll in treatment for 15-18 weeks.
|
|
Other: iSWAB-DNA
Students that give prior consent to participating in DNA buccal swabs and the mindfulness curriculum are randomly selected to give buccal swabs prior to and after the mindfulness curriculum intervention.
A subset of those students that qualify for CCT will give another buccal swab after CCT completion.
DNA will be sent to Dr. Urban's lab for analysis of genetic resilience markers.
|
The Start with the Heart curriculum includes psychoeducation, lessons, and activities, on mindfulness, neurobiology, meditation, positive thinking, movement, and nutrition to promote well-being.
The curriculum will be taught in the classroom to students for 15-20 min per day for 6-8 weeks.
Students who report a threshold of PTSD symptoms will be offered participation in Cue-Centered Therapy with their school counselors.
They will have one-on-one therapy that targets trauma experiences through cognitive behavioral tools, narrative therapy, exposure therapy, psychoeducation, and more.
Their caregivers will be involved as needed.
They will enroll in treatment for 15-18 weeks.
Eligible students will give DNA buccal swabs at 2-3 time points for later analysis of genetic markers.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mean Change from Baseline in Resilience Score
Time Frame: Three time points: Baseline, week 8, week 23
|
Resilience is assessed using the Child/Youth and Adult Resilience Measure on a 5- point Likert scale.
Score range 1 to 5 (1=Not at all, 5=A lot).
The total score is summed.
Changes in scores will be assessed between all time points.
|
Three time points: Baseline, week 8, week 23
|
|
Mean Change from Baseline in Work Self-Efficacy Score
Time Frame: Teachers: Baseline, week 8; Counselors: Baseline, week 23
|
Work Self-Efficacy is assessed on a 5- point Likert scale.
Score range 1 to 5 (1=Not well at all, 5=Very Well).
The total score is summed.
Changes in scores will be assessed between all time points.
|
Teachers: Baseline, week 8; Counselors: Baseline, week 23
|
|
Mean Change from Baseline in Somatic Symptoms Score
Time Frame: Three time points: Baseline, week 8, week 23
|
Somatic symptoms are assessed using the PHQ-15 on a 3- point Likert scale.
Score range 0 to 2 (0=Not bothered at all, 2=Bothered a lot).
Total score is summed.
Changes in scores will be assessed between all time points.
|
Three time points: Baseline, week 8, week 23
|
|
Changes in Methylation Pattern of Genes
Time Frame: Three time points: Baseline, week 8, week 23
|
Using DNA methylation to analyze DNA samples from buccal swabs to investigate genetic markers of resilience.
Genetic markers to be analyzed include: CTNNB1, ITGB8, CSRP2, WTAP, TSC22D1, HNRNPH1, NTRK2, DCX, CDK14, PTNN, SLC1A3, IGFBP2, ERBB4.
Changes in genetic expressions will be assessed between all time points.
|
Three time points: Baseline, week 8, week 23
|
|
Mean Change from Baseline in Anxiety Score
Time Frame: Three time points: Baseline, week 8, week 23
|
Generalized Anxiety Disorder (GAD) symptoms are assessed using the GAD-7 on a 4- point Likert scale.
Score range 0 to 3 (0=Not at all, 3=Nearly every day).
Total score is summed.
Changes in scores will be assessed between all time points.
|
Three time points: Baseline, week 8, week 23
|
|
Mean Change from Baseline in Depression Score
Time Frame: Three time points: Baseline, week 8, week 23
|
Depression is assessed using the Patient Health Questionnaire (PHQ)-8 on a 4- point Likert scale.
Score range 0 to 3 (0=Not at all, 3=Nearly every day).
Total score is summed.
Changes in scores will be assessed between all time points.
|
Three time points: Baseline, week 8, week 23
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mean Change from Baseline in Family Functioning Score
Time Frame: Three time points: Baseline, week 8, week 23
|
Family functioning are assessed using the Family Assessment Device on a 4- point Likert scale.
Score range 1 to 4 (1=Strongly Agree, 4=Strongly Disagree).
Unhealthy responses are reverse-scored and each subscale is averaged.
Only the General Functioning subscale will be used for the study.
Changes in scores will be assessed between all time points.
|
Three time points: Baseline, week 8, week 23
|
|
Mean Change from Baseline in Sleep Quality Score
Time Frame: Three time points: Baseline, week 8, week 23
|
Sleep quality is assessed using the Brief-Pittsburgh Sleep Quality Index.
Questions are open answer (i.e.
When have you usually gone to bed at night?
How many hours of actual sleep did you get at night?).
Total score is calculated by summing subscores of sleep duration, latency, day dysfunction, sleep efficiency, sleep quality, and meds.
Changes in scores will be assessed between all time points.
|
Three time points: Baseline, week 8, week 23
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Victor Carrion, M.D., John A. Turner, M.D. Professor and Vice-Chair of Psychiatry and Behavioral Sciences at Stanford University and Director of the Stanford Early Life Stress and Resilience Program
- Principal Investigator: Alexander Urban, Ph.D., Associate professor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB-67441
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stress
-
Massachusetts General HospitalCompletedStress | Emotional Stress | Psychological Stress | Social Stress | Life StressUnited States
-
Center for Advanced Facial Plastic SurgeryCompletedStress | Stress, Physiological | Stress Response | Stress (Psychology) | Healthy Adult Female Participants | Stress, Psychologic | Stress Perception | Stress Levels | Stress, Psychological CumulativeUnited States
-
Amsterdam UMC, location VUmcRigshospitalet, Denmark; Universitätsklinikum Hamburg-EppendorfNot yet recruitingStress | Stress and Burnout | Stress BiomarkersGermany, Denmark
-
University of California, Los AngelesUniversity of California, San Francisco; Stanford University; California Initiative...CompletedStress | Stress, Psychological | Stress, Emotional | Stress, Physiological | Stress ReactionUnited States
-
Amasya UniversityCompletedThe Effect of Online Stress Management Program on Nurses' Individual Workload Perception, and StressStress | Nursing | Stress ManagementTurkey (Türkiye)
-
Canterbury Christ Church UniversitySussex Partnership NHS Foundation TrustEnrolling by invitationOccupational Stress or Workplace StressUnited Kingdom
-
University of PadovaCompletedStress | Stress Disorder | Work Related StressItaly
-
University of Thi-QarCompletedPsychological Stress | Academic StressIraq
-
Dana-Farber Cancer InstituteCompletedStress | Post Traumatic Stress Disorder | Work Related StressUnited States
-
University of North Carolina, Chapel HillWashington University School of Medicine; United States Department of Defense; University of Florida and other collaboratorsRecruitingPost-traumatic Stress Disorder | Acute Stress Disorder | Acute Stress ReactionUnited States
Clinical Trials on Start with the Heart Students
-
Assistance Publique - Hôpitaux de ParisCIA : CNGE IRMG Association; CNGE : Collège National des Généralistes Enseignants and other collaboratorsCompleted
-
University of ArizonaNational Cancer Institute (NCI); Michigan State UniversityCompleted
-
LeMaitre VascularCompleted
-
University of MiamiCompletedMental Health Wellness 1United States
-
University Hospital, GhentCompleted
-
University Hospital, Strasbourg, FranceCompleted
-
Chia-hsi ChenActive, not recruiting
-
Bilecik Seyh Edebali UniversitesiCompletedEducation, Nursing | Students, NursingTurkey
-
University of Maryland, BaltimoreNational Institute on Drug Abuse (NIDA)CompletedHIV | Drug Use DisordersUnited States
-
The University of Texas Health Science Center at...The Office of Adolescent Health, HHSCompleted